{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "12027771", "DateCompleted": {"Year": "2002", "Month": "08", "Day": "08"}, "DateRevised": {"Year": "2019", "Month": "09", "Day": "06"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0163-3864", "JournalIssue": {"Volume": "65", "Issue": "5", "PubDate": {"Year": "2002", "Month": "May"}}, "Title": "Journal of natural products", "ISOAbbreviation": "J Nat Prod"}, "ArticleTitle": "The antiplasmodial activity of isolates from Ajuga remota.", "Pagination": {"StartPage": "789", "EndPage": "793", "MedlinePgn": "789-93"}, "Abstract": {"AbstractText": ["Ajuga remota is the most frequently used medicinal herb for malaria treatment in Kenya. Its two known isolates ajugarin-1 (1) and ergosterol-5,8-endoperoxide (3) and a new isolate 8-O-acetylharpagide (2) were evaluated for their in vitro antiplasmodial activity. Ajugarin-1 was moderately active, with an IC(50) of 23.0 +/- 3.0 microM, as compared to chloroquine (IC(50) = 0.041 +/- 0.003 microM) against the chloroquine-sensitive (FCA 20/GHA) strain of Plasmodium falciparum. Ergosterol-5,8-endoperoxide was about 3x as potent (IC(50) = 8.2 +/- 1.1 microM), while 8-O-acetylharpagide, whose structure was established by spectroscopic evidence, was inactive. Both ajugarin-1 and ergosterol-5,8-endoperoxide did not exhibit cytotoxicity against A431 (skin carcinoma) cell line, but 8-O-acetylharpagide was significantly cytotoxic. This iridoid glucoside, which has been formerly isolated from Ajuga decumbens, was identified in A. remota for the first time."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Pharmacy, University of Nairobi, P.O. Box 19676, Nairobi, Kenya."}], "Identifier": [], "LastName": "Kuria", "ForeName": "Kimani A M", "Initials": "KA"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Chepkwony", "ForeName": "Hezekiah", "Initials": "H"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Govaerts", "ForeName": "Cindy", "Initials": "C"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Roets", "ForeName": "Eugene", "Initials": "E"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Busson", "ForeName": "Roger", "Initials": "R"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "De Witte", "ForeName": "Peter", "Initials": "P"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Zupko", "ForeName": "Istvan", "Initials": "I"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Hoornaert", "ForeName": "Georges", "Initials": "G"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Quirynen", "ForeName": "Ludo", "Initials": "L"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Maes", "ForeName": "Louis", "Initials": "L"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Janssens", "ForeName": "Leen", "Initials": "L"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Hoogmartens", "ForeName": "Jos", "Initials": "J"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Laekeman", "ForeName": "Gert", "Initials": "G"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Nat Prod", "NlmUniqueID": "7906882", "ISSNLinking": "0163-3864"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antimalarials"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Diterpenes"}, {"RegistryNumber": "62640-05-5", "NameOfSubstance": "ajugarin I"}, {"RegistryNumber": "886U3H6UFF", "NameOfSubstance": "Chloroquine"}, {"RegistryNumber": "EC 1.1.1.27", "NameOfSubstance": "L-Lactate Dehydrogenase"}, {"RegistryNumber": "U3P01618RT", "NameOfSubstance": "Fluorouracil"}, {"RegistryNumber": "UG9TN81TGH", "NameOfSubstance": "ergosterol-5,8-peroxide"}, {"RegistryNumber": "Z30RAY509F", "NameOfSubstance": "Ergosterol"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Antimalarials"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Chloroquine"}, {"QualifierName": [], "DescriptorName": "Chromatography, Thin Layer"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Diterpenes"}, {"QualifierName": ["physiology"], "DescriptorName": "Drug Resistance, Microbial"}, {"QualifierName": [], "DescriptorName": "Drug Screening Assays, Antitumor"}, {"QualifierName": ["analogs & derivatives", "chemical synthesis"], "DescriptorName": "Ergosterol"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Fluorouracil"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "In Vitro Techniques"}, {"QualifierName": [], "DescriptorName": "Inhibitory Concentration 50"}, {"QualifierName": [], "DescriptorName": "Kenya"}, {"QualifierName": ["metabolism"], "DescriptorName": "L-Lactate Dehydrogenase"}, {"QualifierName": ["chemistry"], "DescriptorName": "Lamiaceae"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["drug effects", "enzymology", "metabolism"], "DescriptorName": "Plasmodium falciparum"}, {"QualifierName": [], "DescriptorName": "Skin Neoplasms"}, {"QualifierName": ["drug effects"], "DescriptorName": "Tumor Cells, Cultured"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2002", "Month": "5", "Day": "25", "Hour": "10", "Minute": "0"}, {"Year": "2002", "Month": "8", "Day": "9", "Hour": "10", "Minute": "1"}, {"Year": "2002", "Month": "5", "Day": "25", "Hour": "10", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["12027771", "10.1021/np0104626", "np0104626"]}}], "PubmedBookArticle": []}